CA-CHARGEPOINT
ChargePoint (NYSE: CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), today announced a suite of updates and additions to its be.ENERGISED platform, a leading European software solution for the management of charging networks and e-mobility services at scale.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619736580/en/
(Photo: Business Wire)
be.ENERGISED now manages over 900 models of charging stations from more than 100 manufacturers. New features, offerings and enhancements include:
- The first payment terminal to meet the new OCPI v2.2.1 Direct Payment Module industry standards and comply with the recently instated AFIR (Alternative Fuel Infrastructure Regulation).
- eMobility Service Providers (eMSPs) can use the solutions’ roaming network to give their drivers selected access to more than 750,000 stations across the whole of Europe. Charge Point Operators (CPOs) can easily make their stations available to the public and all drivers on the major eMSPs via be.ENERGISED COMMUNITY roaming agreements in just a few clicks of a mouse.
- In addition, the CP6000 - ChargePoint’s most flexible and serviceable global AC EV charging solution - is available from this week on the be.ENERGISED platform to select customers. The CP6000 is designed for scalability, flexibility, and reliability, offering reliable AC charging for 1 or 3 phase power at an adaptable output of 3.7 to 22kw per port.
ChargePoint’s be.ENERGISED platform boasts consolidated services for CPOs and eMSPs, including VAT handling, automated invoicing, streamlining financial operations for multinational charging providers. With over 85,000 charging ports and 30 million charging sessions per month, be.ENERGISED’s scale and experience are unparalleled in the industry. The software offers an end-to-end solution capable of addressing every aspect of the charging process, providing unmatched flexibility and modularity to cater to all use cases.
The EV charging landscape is rapidly evolving, with CPOs and eMSPs becoming far more sophisticated, often relying on many makes of chargers and hundreds of software integrations with partners. As their expertise deepens, so do their needs, transforming from initial solutions into intricate networks which require robust protection and management. This shift signifies a move from the early days of greenfield projects to the current “brownfield” environment, where existing charger investments must be futureproofed alongside the implementation of new infrastructure. Though new chargers are constantly being brought online, ensuring a reliable network requires legacy hardware running just as well as the newest installations. All of this underscores the need for a well-rounded, adaptable software solution such as be.ENERGISED.
“A new set of market demands necessitates even the most advanced charger management platforms to deliver innovative features for the future,” said Andreas Blin, Director for Service Provision at ChargePoint. “A leader in the market for more than a decade, be.ENERGISED meets the challenges charging businesses face, ensuring that both new and existing infrastructure can excel in an ever more dynamic environment.”
Since acquiring be.ENERGISED three years ago, ChargePoint has continued to foster and develop the product to ensure market leadership while delivering bespoke solutions for international customers. be.ENERGISED is now the most flexible and comprehensive solution on the market, and one built for the future without forgetting about the past.
To learn more about ChargePoint’s be.ENERGISED platform, please click here or visit the ChargePoint stand B6.111Hall B6 at the Power2Drive charging infrastructure exposition in Munich held June 19-21st.
About ChargePoint Holdings, Inc.
ChargePoint is creating a new fuelling network to move people and goods on electricity. Since 2007, ChargePoint has been committed to making it easy for businesses and drivers to go electric with one of the largest EV charging networks and a comprehensive portfolio of charging solutions. The ChargePoint cloud subscription platform and software-defined charging hardware are designed to include options for every charging scenario from home and multifamily to workplace, parking, hospitality, retail, and transport fleets of all types. Today, one ChargePoint account provides access to hundreds-of-thousands of places to charge in North America and Europe. For more information, visit the ChargePoint pressroom, the ChargePoint Investor Relations site, or contact the ChargePoint North American or European press office or Investor Relations.
CHPT-IR
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240619736580/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom